Pancreatic Cancer Research

ResearcherSingHealthActive in the last 2 years

Yun Zhao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2508-0185; OpenAlex author ID A5101662898. Sources: OpenAlex.

Their work

Papers
5 (first author 4, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2025: 3 papers · 2026: 2 papers

Papers 5

  1. Pancreatic cancer burden across Southeast Asia from 1990 to 2021: An analysis of incidence and mortality based on the global burden of disease study 2021. First author DOI 10.1016/j.pan.2025.09.031↗
  2. Neoadjuvant therapy versus upfront surgery for resectable pancreatic cancer: Updated systematic review, individual-patient-data meta-analysis and trial sequent… First author DOI 10.1016/j.surg.2025.109872↗
  3. SEER-based evaluation of lymph node yield as a prognostic indicator of cancer-specific survival in nonmetastatic pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.pan.2025.05.008↗
  4. Clinical Outcomes of Neoadjuvant Therapy Versus Upfront Surgery in Resectable Pancreatic Cancer: Systematic Review and Meta-analysis of Latest Randomized Contr… First author DOI 10.1245/s10434-024-16674-y↗
  5. Survival Outcomes in Nonmetastatic pT4 Pancreatic Ductal Adenocarcinoma: A SEER Database Analysis Comparing Neoadjuvant Therapy and Upfront Surgery with Propen… Co-author DOI 10.31557/apjcp.2025.26.3.847↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ye Xin Koh · 5 shared papers, 2025–2026 · strength 1.49
  2. Brian K. P. Goh · 5 shared papers, 2025–2026 · strength 1.49
  3. Hwee Leong Tan · 4 shared papers, 2025–2026 · strength 1.12
  4. Kennedy Yao Yi Ng · 2 shared papers, 2025–2026 · strength 0.55
  5. Joycelyn Jie Xin Lee · 2 shared papers, 2025–2026 · strength 0.55
  6. David Wai-Meng Tai · 2 shared papers, 2025–2026 · strength 0.55
  7. Anna Ho Yin Chan · 1 shared paper, 2025 · strength 0.25

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.